Company / Capital Returned to Shareholders per Share
Vertex Pharmaceuticals Capital Returned to Shareholders per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$7.85
FY2025
5-year range
$0.00 / $7.85
FY2021-FY2025
Trend
+71.9%
vs FY2024
Sector context
#5 of 51
Health Care
What the data says
Among 51 Health Care companies, Vertex Pharmaceuticals is in the top 10% for capital returned to shareholders per share. Capital Returned to Shareholders per Share has increased for 3 consecutive years, from $0.00 in FY2022 to $7.85 in FY2025.
Based on SEC 10-K filings.
7.85 in FY2025 with a 5-year CAGR of +30.4%. Top quartile in the Health Care sector.
Improved from $1.66 to $7.85 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +30.4%
- 10-Year CAGR
- -
Sector benchmark
+187.0% above sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders per share increased 71.9% year-over-year.
- Ranks #5 out of 51 companies in the Health Care sector.
- Lowest capital returned to shareholders per share in the period was in FY2022.
Company context
Key Data Points
- Strong profit margin: 31.4%
- Strong return on equity: 21.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.85 | +71.9% |
| FY2024 | $4.57 | +174.6% |
| FY2023 | $1.66 | - |
| FY2022 | $0.00 | -100.0% |
| FY2021 | $5.48 | +163.5% |
| FY2020 | $2.08 | +185.6% |
| FY2019 | $0.73 | -47.3% |
| FY2018 | $1.38 | - |
| FY2017 | $0.00 | - |
| FY2016 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Mar 17, 2026